TNFRSF1A and metabolic dysfunction-associated steatohepatitis: Although the precise role of Fas and TNFR in NASH in vivo is still controversial, it has been shown that lack of TRAIL-R is protective, as TRAIL-R-deficient mice display reduced steatosis, inflammation and fibrosis in association with lower hepatocyte apoptosis [164].